AI Digital Therapeutics Designer
An AI Digital Therapeutics Designer architects evidence-based, software-driven therapeutic interventions that leverage machine lea…
Skill Guide
The specialized knowledge of regulatory frameworks governing the commercialization of digital health products, specifically FDA's Digital Health Technologies (DHT) and Prescription Digital Therapeutics (PDT) guidance, the EU's Medical Device Regulation (MDR) for software, and the data privacy mandates of HIPAA (US) and GDPR (EU).
Scenario
You are the product manager for 'MindfulRx', a new app that uses AI chatbots to deliver Cognitive Behavioral Therapy (CBT) for anxiety, claiming to improve clinical outcomes.
Scenario
Post-launch in the EU (under MDR), a bug is discovered in 'MindfulRx' that occasionally sends aggregated, anonymized user data to a non-EU analytics vendor without explicit, granular consent for that specific transfer.
Scenario
The board wants to fast-track 'MindfulRx' as an FDA-cleared PDT (prescription-only) for Generalized Anxiety Disorder (GAD) and simultaneously launch as a Class IIb medical device under EU MDR.
These are the foundational documents and templates for structuring compliant submissions. The IMDRF framework is the universal language for risk categorizing SaMD globally.
NIST and ISO 27001 are used to build the technical security controls. ISO 13485 is the required QMS for any company seeking CE marking. OneTrust-type platforms operationalize privacy impact assessments and consent management.
TPLC is the FDA's paradigm for ongoing evidence generation. 'By Design' methodologies ensure compliance is engineered in from the start. The JRA is a critical strategic document for novel products to align with regulators early.
Answer Strategy
The question tests strategic foresight and the ability to build a transitional regulatory roadmap. Structure the answer around intended use, data collection, and QMS. Sample Answer: 'First, we must clearly demarcate the intended use in all materials: for wellness, it's for general awareness; for medical, it's for clinical decision-making. From day one, we must collect data under a protocol suitable for future clinical validation, securing informed consent that covers future research use. We must build a QMS (ISO 13485) from the start, even for the wellness version, to ensure data integrity and traceability. The data storage must immediately meet HIPAA standards for PHI, treating all sensor data as potentially protected once the medical intent is declared.'
Answer Strategy
This behavioral question assesses conflict resolution, stakeholder management, and risk communication. Use the STAR method (Situation, Task, Action, Result). Frame your action as translating between business and regulatory languages. Sample Answer: 'In my previous role, sales wanted to claim our AI triage tool 'diagnoses' conditions to close deals, which would have made it a high-risk SaMD requiring PMA approval we didn't have. I facilitated a workshop where I translated the regulatory risk (FDA warning letters, market withdrawal) into business impact (loss of key accounts, lawsuits). I proposed a compromise: we could market it as a 'clinical decision support tool' with clear disclaimers and use the sales momentum to accelerate our actual De Novo submission for a narrower, cleared indication. This aligned the teams on a compliant path to revenue.'
1 career found
Try a different search term.